GRAIL (MEX:GRAL) Asset Impairment Charge : MXN26,037 Mil (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is GRAIL Asset Impairment Charge?

GRAIL's Asset Impairment Charge for the three months ended in Mar. 2025 was MXN6 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 was MXN26,037 Mil.

GRAIL Asset Impairment Charge Historical Data

The historical data trend for GRAIL's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GRAIL Asset Impairment Charge Chart

GRAIL Annual Data

Trend

Dec18

Dec19

Dec22

Dec23

Dec24

Asset Impairment Charge

111.08

41.85

91,639.60

12,195.42

29,634.62

GRAIL Quarterly Data
	Dec18	Dec19	Jun20	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Asset Impairment Charge	Get a 7-Day Free Trial								-	26,031.69	-	-	5.59

GRAIL Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN26,037 Mil.

GRAIL Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of GRAIL's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

GRAIL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (MEX:GRAL) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

GRAL:USA NL0:Germany NL0:Germany

Address

1525 O’Brien Drive, Menlo Park, CA, USA, 94025

Website

https://www.grail.com

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.